About HandyLab
HandyLab is a company based in Ann Arbor (United States) founded in 1999 was acquired by Becton Dickinson in October 2009. HandyLab has raised $30.7 million across 4 funding rounds from investors including Pfizer, HP and BD. HandyLab operates in a competitive market with competitors including Prenetics, Karius, Day Zero Diagnostics, OpGen and Clear Labs, among others.
- Headquarter Ann Arbor, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Handylab, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$30.7 M (USD)
in 4 rounds
-
Latest Funding Round
$19.2 M (USD), Series D
Aug 04, 2008
-
Investors
Pfizer
& 8 more
-
Employee Count
Not available
-
Acquired by
Becton Dickinson
(Oct 23, 2009)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of HandyLab
HandyLab has successfully raised a total of $30.7M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $19.2 million completed in August 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in HandyLab
HandyLab has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Pfizer, HP and BD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage US tech and life science companies are invested in.
|
Locked | Locked | Locked | |
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Locked | Locked | Locked | |
|
A platform dedicated to partnership marketing insights.
|
Locked | Locked | Locked |
Investor details for HandyLab
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HandyLab
Investment portfolio details for HandyLab
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HandyLab
Detailed financials for HandyLab
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Handylab Comparisons
Peer comparison for HandyLab
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HandyLab
HandyLab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, Karius, Day Zero Diagnostics, OpGen and Clear Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Food safety technologies are provided for pathogen identification.
|
|
| Locked | Locked | Locked |
Viral infection treatments are developed using nucleic acid hybrid chemistry.
|
Detailed competitors of HandyLab
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Handylab
Complete news archive for HandyLab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HandyLab
HandyLab was founded in 1999 and raised its 1st funding round 1 year after it was founded.
HandyLab is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
HandyLab is a funded company, having raised a total of $30.7M across 4 funding rounds to date.
HandyLab was founded in 1999 in Ann Arbor, United States, and operates within the biotechnology sector focused on molecular diagnostics. Assays and automation platforms are developed, including the HandyLab Jaguar system, which integrates sample preparation, nucleic acid extraction, and real-time PCR amplification and detection. This bench-top setup supports on-demand and batch processing for clinical workflows, with results generated in real time.
HandyLab's top competitors include Prenetics, Clear Labs and Day Zero Diagnostics.
HandyLab has 9 investors. Key investors include Pfizer, HP, BD, Dow, and EDF Ventures.